Owner Janssen Pharmaceutica N.V.

Inventors Chen, Jinsheng; Wilson, Kenneth; Wall, Mark; Meegalla, Sanath K.; Illig, Carl R.; Ballentine, Shelley K.; Desjarlais, Renee Louise; Tomczuk, Bruce E.

Agent Shelston IP

Pub. Number AU-B-2007240440

PCT Pub. Number WO2007/124319

Priority 60/793,667 20.04.06 US

Filing date 18 April 2007

Wipo publication date 1 November 2007

Acceptance publication date 20 September 2012

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 31/382 - having six-membered rings, e.g. thioxanthenes

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4178

A61K 31/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5355 - Non-condensed oxazines containing further heterocyclic rings

A61P 11/00 Drugs for disorders of the respiratory system

A61P 13/00 Drugs for disorders of the urinary system

A61P 35/00 Antineoplastic agents

C07D 233/90 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 493/08 Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system